vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.
GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $13.3M, roughly 1.7× OCULAR THERAPEUTIX, INC). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -488.0%, a 534.3% gap on every dollar of revenue. On growth, GREENE COUNTY BANCORP INC posted the faster year-over-year revenue change (23.8% vs -22.4%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $-57.1M). Over the past eight quarters, GREENE COUNTY BANCORP INC's revenue compounded faster (18.9% CAGR vs -5.3%).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
GCBC vs OCUL — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $13.3M |
| Net Profit | $10.3M | $-64.7M |
| Gross Margin | — | 88.0% |
| Operating Margin | 52.0% | -526.5% |
| Net Margin | 46.3% | -488.0% |
| Revenue YoY | 23.8% | -22.4% |
| Net Profit YoY | 37.4% | -33.6% |
| EPS (diluted) | $0.60 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.2M | $13.3M | ||
| Q3 25 | $21.5M | $14.5M | ||
| Q2 25 | $20.5M | $13.5M | ||
| Q1 25 | $20.1M | $10.7M | ||
| Q4 24 | $17.9M | $17.1M | ||
| Q3 24 | $16.9M | $15.4M | ||
| Q2 24 | $16.6M | $16.4M | ||
| Q1 24 | $15.7M | $14.8M |
| Q4 25 | $10.3M | $-64.7M | ||
| Q3 25 | $8.9M | $-69.4M | ||
| Q2 25 | $9.3M | $-67.8M | ||
| Q1 25 | $8.1M | $-64.1M | ||
| Q4 24 | $7.5M | $-48.4M | ||
| Q3 24 | $6.3M | $-36.5M | ||
| Q2 24 | $6.7M | $-43.8M | ||
| Q1 24 | $5.9M | $-64.8M |
| Q4 25 | — | 88.0% | ||
| Q3 25 | — | 87.8% | ||
| Q2 25 | — | 85.6% | ||
| Q1 25 | — | 88.2% | ||
| Q4 24 | — | 92.8% | ||
| Q3 24 | — | 89.9% | ||
| Q2 24 | — | 90.8% | ||
| Q1 24 | — | 91.0% |
| Q4 25 | 52.0% | -526.5% | ||
| Q3 25 | 47.4% | -472.3% | ||
| Q2 25 | 53.5% | -502.6% | ||
| Q1 25 | 44.6% | -597.5% | ||
| Q4 24 | 45.0% | -296.1% | ||
| Q3 24 | 39.6% | -298.2% | ||
| Q2 24 | 41.2% | -265.1% | ||
| Q1 24 | 39.4% | -214.0% |
| Q4 25 | 46.3% | -488.0% | ||
| Q3 25 | 41.2% | -477.3% | ||
| Q2 25 | 45.6% | -503.9% | ||
| Q1 25 | 40.1% | -598.7% | ||
| Q4 24 | 41.7% | -283.3% | ||
| Q3 24 | 37.1% | -236.6% | ||
| Q2 24 | 40.6% | -266.3% | ||
| Q1 24 | 37.3% | -438.9% |
| Q4 25 | $0.60 | $-0.27 | ||
| Q3 25 | $0.52 | $-0.38 | ||
| Q2 25 | $0.55 | $-0.39 | ||
| Q1 25 | $0.47 | $-0.38 | ||
| Q4 24 | $0.44 | $-0.25 | ||
| Q3 24 | $0.37 | $-0.22 | ||
| Q2 24 | $0.39 | $-0.26 | ||
| Q1 24 | $0.34 | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $737.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $258.3M | $654.3M |
| Total Assets | $3.1B | $808.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $737.1M | ||
| Q3 25 | — | $344.8M | ||
| Q2 25 | — | $391.1M | ||
| Q1 25 | $155.5M | $349.7M | ||
| Q4 24 | $166.4M | $392.1M | ||
| Q3 24 | — | $427.2M | ||
| Q2 24 | $190.4M | $459.7M | ||
| Q1 24 | — | $482.9M |
| Q4 25 | $258.3M | $654.3M | ||
| Q3 25 | $248.2M | $258.2M | ||
| Q2 25 | $238.8M | $305.9M | ||
| Q1 25 | $229.0M | $265.9M | ||
| Q4 24 | $218.4M | $315.3M | ||
| Q3 24 | $216.3M | $352.0M | ||
| Q2 24 | $206.0M | $377.7M | ||
| Q1 24 | $199.2M | $408.0M |
| Q4 25 | $3.1B | $808.1M | ||
| Q3 25 | $3.1B | $410.9M | ||
| Q2 25 | $3.0B | $451.3M | ||
| Q1 25 | $3.0B | $405.9M | ||
| Q4 24 | $3.0B | $457.9M | ||
| Q3 24 | $2.9B | $490.4M | ||
| Q2 24 | $2.8B | $517.1M | ||
| Q1 24 | $2.9B | $538.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $-54.2M |
| Free Cash FlowOCF − Capex | $6.2M | $-57.1M |
| FCF MarginFCF / Revenue | 28.0% | -430.9% |
| Capex IntensityCapex / Revenue | 0.9% | 21.4% |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | $-216.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $-54.2M | ||
| Q3 25 | $7.0M | $-50.7M | ||
| Q2 25 | $28.0M | $-55.2M | ||
| Q1 25 | $7.3M | $-44.7M | ||
| Q4 24 | $5.3M | $-39.4M | ||
| Q3 24 | $2.1M | $-36.6M | ||
| Q2 24 | $24.9M | $-24.8M | ||
| Q1 24 | $5.6M | $-33.9M |
| Q4 25 | $6.2M | $-57.1M | ||
| Q3 25 | $6.5M | $-56.7M | ||
| Q2 25 | $27.3M | $-56.5M | ||
| Q1 25 | $7.3M | $-46.6M | ||
| Q4 24 | $5.1M | $-39.6M | ||
| Q3 24 | $2.0M | $-36.6M | ||
| Q2 24 | $23.4M | $-25.5M | ||
| Q1 24 | $4.9M | $-34.1M |
| Q4 25 | 28.0% | -430.9% | ||
| Q3 25 | 30.4% | -390.0% | ||
| Q2 25 | 133.3% | -419.7% | ||
| Q1 25 | 36.1% | -435.6% | ||
| Q4 24 | 28.6% | -232.0% | ||
| Q3 24 | 11.8% | -237.6% | ||
| Q2 24 | 141.2% | -155.4% | ||
| Q1 24 | 31.3% | -231.1% |
| Q4 25 | 0.9% | 21.4% | ||
| Q3 25 | 1.9% | 41.2% | ||
| Q2 25 | 3.4% | 9.3% | ||
| Q1 25 | 0.3% | 18.1% | ||
| Q4 24 | 1.0% | 1.2% | ||
| Q3 24 | 0.9% | 0.6% | ||
| Q2 24 | 9.1% | 4.5% | ||
| Q1 24 | 4.2% | 1.7% |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 3.70× | — | ||
| Q1 24 | 0.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
